Iktos is pleased to announce it has become an Advanced Technology Partner in the AWS Partner Network and joined the AWS ISV (Independent Software Vendor) Accelerate co-sell program. As part of this collaboration, Iktos has made Makya, its innovative de novo drug design tool, available on the AWS Marketplace.
To learn more about this announcement follow this link.
